BIIB
BIIB news
Latest 7 stories · newest Oct 29, 2026
BIIB
Biogen Q3 2026 revenue grows 11% to $2.8 billion
Biogen reported an 11% year-over-year increase in third quarter revenue to $2.8 billion as its growth portfolio delivered 49% growth, highlighting a return to growth. The company raised its full-year 2026 Non-GAAP diluted EPS guidance range to reflect ongoing business strength and favorable Apellis …
BIIB
Biogen Q2 2026 revenue rises 3% to $2.7 billion
Biogen reported $2.7 billion in second quarter revenue, up 3% year-over-year, with strong contributions from growth portfolio products and the recently acquired Apellis assets.
BIIB
BIIB
BIIB
BIIB
Biogen and Denali discontinue BIIB122 development after Phase 2b failure in Parkinson's
The Phase 2b LUMA study of BIIB122 failed to meet primary and secondary endpoints in early-stage Parkinson's disease, prompting discontinuation in idiopathic PD while continuing a separate LRRK2 carrier study. The setback represents a significant clinical disappointment for both companies in the neu…
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same BIIB feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/BIIB/newsSTART FREE